Wockhardt Limited
News and overview for Wockhardt Limited
Wockhardt sells Luton facility to Bristol Labs
Financial Express (India), The | 5 days 13 hours 26 minutes ago
Wockhardt UK Ltd, the British arm of Indian pharmaceutical major Wockhardt Limited, on Thursday said that the company has sold its Luton plant near London to UK-based Bristol Laboratories. In a media statement, Wockhardt has said that the products of Wallis manufactured earlier at Luton, have been shifted to CP Pharmaceuticals plant at Wrexham in Wales, and to Wockhardts plants in India.
Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009 [Press Release]
PRNewswire | 41 days 4 hours 59 minutes ago
ABBOTT PARK, Ill., Oct. 14 /PRNewswire-FirstCall/ -- Abbott
Research and Markets: The Complete CMO Market Outlook: Includes Emerging Markets, Key Players and Future Trends [Press Release]
Business Wire | 9 hours 46 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/dcc5c0/the_cmo_market_out) has announced the addition of the "The CMO Market Outlook: Emerging Markets, Key Players and Future Trends" report to their offering.
2009 India Excellence in Healthcare Awards [Press Release]
PRNewswire | 76 days 12 hours 44 minutes ago
MUMBAI, India, September 9 /PRNewswire/ --
4 Results
Sign up for BIO SmartBrief
Company Overview
| Company: | Wockhardt Limited |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.wockhardt.com |
Wockhardt works hard in the pharmaceutical world. The research and pharmaceutical manufacturing firm employs more than 500 scientists who focus on recombinant biopharmaceuticals, generics, and new drug discovery. Wockhardt's products include injectables, tablets, liquids, and topicals (creams and ointments) that it manufactures to sell itself and for AstraZeneca, Sanofi-Aventis, Cell Therapeutics, Schering-Plough, and other major drug companies. It operates 15 manufacturing plants in India, the UK, Ireland, France, and the US, and has filed more than 250 patents for biotechnology products. The company is a subsidiary of Khorakiwala Holdings and Investments.
Key Numbers
| Sales in U.S. Dollars (mil.) | 0 () |
|---|---|
| One-year % Growth in Sales | 0.0 () |
| Net Income in U.S. Dollars (mil.) | 0 () |
| One-year % Growth in Net Income | 0.0 () |
| Number of Employees | 0 (0) |
| One-year % Growth in Number of Employees | 0.0 (0) |
| Fiscal Year-End | December |